|
Zinc in PDB 7pkk: Lpxc Inhibitors with Fluoroproline As A Novel Zinc-Binding Group Can Serve As A Novel Class of Antibiotic with Activity Against Multidrug- Resistant Gram-Negative BacteriaEnzymatic activity of Lpxc Inhibitors with Fluoroproline As A Novel Zinc-Binding Group Can Serve As A Novel Class of Antibiotic with Activity Against Multidrug- Resistant Gram-Negative Bacteria
All present enzymatic activity of Lpxc Inhibitors with Fluoroproline As A Novel Zinc-Binding Group Can Serve As A Novel Class of Antibiotic with Activity Against Multidrug- Resistant Gram-Negative Bacteria:
3.5.1.108; Protein crystallography data
The structure of Lpxc Inhibitors with Fluoroproline As A Novel Zinc-Binding Group Can Serve As A Novel Class of Antibiotic with Activity Against Multidrug- Resistant Gram-Negative Bacteria, PDB code: 7pkk
was solved by
M.D.Ryan,
T.D.Pallin,
M.B.A.C.Lamers,
P.M.Leonard,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Other elements in 7pkk:
The structure of Lpxc Inhibitors with Fluoroproline As A Novel Zinc-Binding Group Can Serve As A Novel Class of Antibiotic with Activity Against Multidrug- Resistant Gram-Negative Bacteria also contains other interesting chemical elements:
Zinc Binding Sites:
The binding sites of Zinc atom in the Lpxc Inhibitors with Fluoroproline As A Novel Zinc-Binding Group Can Serve As A Novel Class of Antibiotic with Activity Against Multidrug- Resistant Gram-Negative Bacteria
(pdb code 7pkk). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total only one binding site of Zinc was determined in the Lpxc Inhibitors with Fluoroproline As A Novel Zinc-Binding Group Can Serve As A Novel Class of Antibiotic with Activity Against Multidrug- Resistant Gram-Negative Bacteria, PDB code: 7pkk: Zinc binding site 1 out of 1 in 7pkkGo back to![]() ![]()
Zinc binding site 1 out
of 1 in the Lpxc Inhibitors with Fluoroproline As A Novel Zinc-Binding Group Can Serve As A Novel Class of Antibiotic with Activity Against Multidrug- Resistant Gram-Negative Bacteria
![]() Mono view ![]() Stereo pair view
Reference:
M.D.Ryan,
T.D.Pallin,
T.Mullins,
T.Blench,
I.Fraser,
J.Dallow,
N.Ahmed,
C.Ellwood,
S.Gaines,
J.Flores,
Y.Blackwell,
C.T.Garcia,
G.Spence,
A.Reeve,
T.Panchal,
B.Dominguez-Fernandez,
P.M.Leonard,
M.B.A.C.Lamers,
A.Arduin,
C.Fotinou,
E.Gancia,
D.E.Clark,
E.Bush,
J.Betts,
C.Richards,
T.Rea-Davies,
A.D.Keefe,
Y.Zhang,
H.T.Soutter,
P.A.Centrella,
M.A.Clark,
J.W.Cuozzo,
C.E.Dumelin,
S.Habeshian,
A.Hunt,
E.A.Sigel,
D.M.Troast,
B.L.M.Dejonge.
Lpxc Inhibitors with Fluoroproline As A Novel Zinc-Binding Group Can Serve As A Novel Class of Antibiotic with Activity Against Multidrug-Resistant Gram-Negative Bacteria To Be Published.
Page generated: Wed Oct 30 09:12:30 2024
|
Last articlesZn in 9MJ5Zn in 9HNW Zn in 9G0L Zn in 9FNE Zn in 9DZN Zn in 9E0I Zn in 9D32 Zn in 9DAK Zn in 8ZXC Zn in 8ZUF |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |